Literature DB >> 20456811

Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight.

Hanna Olausson1, Marie Löf, Kerstin Brismar, Elisabet Forsum, Annica Sohlström.   

Abstract

Maternal nutritional status, e.g. body weight and composition, is associated with fetal growth. It has been suggested that the insulin-like growth factor (IGF) system may be a mediator of this relationship. In twenty-three healthy Swedish women, we studied (1) the relationships before and during pregnancy between maternal serum concentrations of IGF-I and IGF binding protein-1 (IGFBP-1) and maternal body weight and composition; (2) interactions between serum concentrations of IGF-I (before and in early pregnancy) and maternal nutritional status in relation to infant birth weight. We found that serum IGF-I during pregnancy was positively correlated with maternal body weight (r 0.47-0.56) and fat-free body weight (r 0.61-0.65), whereas serum IGFBP-1 was negatively correlated with maternal body weight (r - 0.44 to - 0.69) and body fat (r - 0.64 to - 0.76) before and during pregnancy. Women with a lower body fat content (%) before pregnancy had greater increases in serum IGFBP-1 during pregnancy than women with a higher prepregnant body fat content (%). In addition, significant fractions of the variation in corrected infant birth weight were explained by variables related to the maternal nutritional status when these were combined with serum concentrations of IGF-I in gestational week 14 (adjusted r2 0.25-0.44, P = 0.001-0.021), but not when they were combined with such concentrations before pregnancy (adjusted r2 0.11-0.12, P = 0.105-0.121). These results suggest mechanisms by which the IGF system may be a mediator between maternal nutritional status and fetal growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456811     DOI: 10.1017/S0007114510001224

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  12 in total

1.  The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Madhulika B Gupta
Journal:  J Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.782

Review 2.  Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

Authors:  Madhulika B Gupta; Thomas Jansson
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

3.  Insulin-like growth factor-binding protein 1 and 7 concentrations are lower in obese pregnant women, women with gestational diabetes and their fetuses.

Authors:  M Lappas
Journal:  J Perinatol       Date:  2014-07-31       Impact factor: 2.521

Review 4.  Placental function in maternal obesity.

Authors:  Amy C Kelly; Theresa L Powell; Thomas Jansson
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

Review 5.  Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction.

Authors:  Jerad H Dumolt; Theresa L Powell; Thomas Jansson
Journal:  Obstet Gynecol Clin North Am       Date:  2021-06       Impact factor: 2.838

6.  Glucose Homeostasis Variables in Pregnancy versus Maternal and Infant Body Composition.

Authors:  Pontus Henriksson; Marie Löf; Elisabet Forsum
Journal:  Nutrients       Date:  2015-07-10       Impact factor: 5.717

7.  Regulation of human trophoblast GLUT1 glucose transporter by insulin-like growth factor I (IGF-I).

Authors:  Marc U Baumann; Henning Schneider; Antoine Malek; Vidya Palta; Daniel V Surbek; Ruth Sager; Stacy Zamudio; Nicholas P Illsley
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

8.  Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers.

Authors:  Vanessa I Ramirez; Evelyn Miller; Christiane L Meireles; Jonathan Gelfond; Debra A Krummel; Theresa L Powell
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-23

9.  Maternal exposure to UV filters: associations with maternal thyroid hormones, IGF-I/IGFBP3 and birth outcomes.

Authors:  M Krause; H Frederiksen; K Sundberg; F S Jørgensen; L N Jensen; P Nørgaard; C Jørgensen; P Ertberg; J H Petersen; U Feldt-Rasmussen; A Juul; K T Drzewiecki; N E Skakkebaek; A M Andersson
Journal:  Endocr Connect       Date:  2018-01-23       Impact factor: 3.335

10.  Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants.

Authors:  Adriana C Vidal; Amy P Murtha; Susan K Murphy; Kimberly Fortner; Francine Overcash; Nikki Henry; Joellen M Schildkraut; Michele R Forman; Wendy Demark-Wahnefried; Joanne Kurtzberg; Randy Jirtle; Cathrine Hoyo
Journal:  Int J Pediatr       Date:  2013-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.